Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity

Innate immune signaling via TLR4 plays critical roles in pathogenesis of metabolic disorders, but the contribution of different lipid species to metabolic disorders and inflammatory diseases is less clear. GM3 ganglioside in human serum is composed of a variety of fatty acids, including long‐chain (LCFA) and very‐long‐chain (VLCFA). Analysis of circulating levels of human serum GM3 species from patients at different stages of insulin resistance and chronic inflammation reveals that levels of VLCFA‐GM3 increase significantly in metabolic disorders, while LCFA‐GM3 serum levels decrease. Specific GM3 species also correlates with disease symptoms. VLCFA‐GM3 levels increase in the adipose tissue of obese mice, and this is blocked in TLR4‐mutant mice. In cultured monocytes, GM3 by itself has no effect on TLR4 activation; however, VLCFA‐GM3 synergistically and selectively enhances TLR4 activation by LPS/HMGB1, while LCFA‐GM3 and unsaturated VLCFA‐GM3 suppresses TLR4 activation. GM3 interacts with the extracellular region of TLR4/MD2 complex to modulate dimerization/oligomerization. Ligand‐molecular docking analysis supports that VLCFA‐GM3 and LCFA‐GM3 act as agonist and antagonist of TLR4 activity, respectively, by differentially binding to the hydrophobic pocket of MD2. Our findings suggest that VLCFA‐GM3 is a risk factor for TLR4‐mediated disease progression.

[1]  A. Suzuki,et al.  Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy , 2018, Glycobiology.

[2]  Fabio Lapenta,et al.  Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists. , 2018, Journal of medicinal chemistry.

[3]  Nils A. Berglund,et al.  Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub , 2018, eLife.

[4]  K. Kabayama,et al.  Biology of GM3 Ganglioside. , 2018, Progress in molecular biology and translational science.

[5]  Masahiro Wakao,et al.  Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands. , 2017, Journal of medicinal chemistry.

[6]  T. Hirokawa,et al.  Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex , 2017, The Journal of Biological Chemistry.

[7]  T. Bamba,et al.  Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity , 2017, Proceedings of the National Academy of Sciences.

[8]  Alicia Llorente,et al.  Lipids in exosomes: Current knowledge and the way forward. , 2017, Progress in lipid research.

[9]  K. Kitajima,et al.  Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation , 2017, The Journal of Biological Chemistry.

[10]  G. Hotamışlıgil.  Inflammation, metaflammation and immunometabolic disorders , 2017, Nature.

[11]  A. Saghatelian,et al.  SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. , 2017, Cell metabolism.

[12]  Soo Jin Kim,et al.  Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4‐MD2 for Efficient LPS Recognition and Transfer , 2017, Immunity.

[13]  K. Iwabuchi,et al.  Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils , 2016, Science Signaling.

[14]  G. Smyth,et al.  GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women , 2016, International Journal of Obesity.

[15]  Y. Igarashi,et al.  Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice , 2016, PloS one.

[16]  Landon R. Whitby,et al.  TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS , 2016, Proceedings of the National Academy of Sciences.

[17]  T. Cullen,et al.  Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria. , 2015, Immunity.

[18]  Y. Yatomi,et al.  Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome , 2015, PloS one.

[19]  K. Shimizu,et al.  Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3. , 2015, Glycobiology.

[20]  S. Summers,et al.  CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. , 2014, Cell metabolism.

[21]  Matthias Blüher,et al.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. , 2014, Cell metabolism.

[22]  F. Villarroya,et al.  Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells , 2014, International Journal of Obesity.

[23]  Kazuro Furukawa,et al.  TLR4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide , 2013, Proceedings of the National Academy of Sciences.

[24]  P. Meikle,et al.  Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance , 2013, Diabetes.

[25]  Toshiyuki Shimizu,et al.  Structural Analyses of Human Toll-like Receptor 4 Polymorphisms D299G and T399I* , 2012, The Journal of Biological Chemistry.

[26]  Marcus D. Hanwell,et al.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.

[27]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[28]  Koichi Fukase,et al.  Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 , 2012, Proceedings of the National Academy of Sciences.

[29]  U. Andersson,et al.  HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease , 2012, Nature Reviews Rheumatology.

[30]  F. Granucci,et al.  CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.

[31]  S. Summers,et al.  Ceramides as modulators of cellular and whole-body metabolism. , 2011, The Journal of clinical investigation.

[32]  B. Beutler,et al.  Toll-like receptors , 2011, Current Biology.

[33]  Carey N Lumeng,et al.  Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.

[34]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[35]  K. Hoshi,et al.  Assisting the diagnosis of Graves' hyperthyroidism with pattern recognition methods and a set of three routine tests parameters, and their correlations with free T4 levels: Extension to male patients. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  Thomas Vogl,et al.  Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel , 2010, Nature Immunology.

[37]  Y. Lo,et al.  Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.

[38]  H. Hama.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. , 2010, Biochimica et biophysica acta.

[39]  Kai Simons,et al.  Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.

[40]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[41]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[42]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[43]  H. Tojo,et al.  Obesity causes a shift in metabolic flow of gangliosides in adipose tissues. , 2009, Biochemical and biophysical research communications.

[44]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[45]  W. Shen,et al.  Inhibition of TLR Activation and Up-Regulation of IL-1R-Associated Kinase-M Expression by Exogenous Gangliosides1 , 2008, The Journal of Immunology.

[46]  Hitoshi Shimano,et al.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance , 2007, Nature Medicine.

[47]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[48]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[49]  Y. Igarashi,et al.  Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[50]  E. Andreeva,et al.  Activation of ganglioside GM3 biosynthesis in human monocyte/macrophages during culturing in vitro , 2007, Biochemistry (Moscow).

[51]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[52]  Y. Satow,et al.  Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.

[53]  Seng H. Cheng,et al.  Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes , 2007, Diabetes.

[54]  Y. Kamei,et al.  Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. , 2007, Biochemical and biophysical research communications.

[55]  J. Heesemann,et al.  Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin‐1 beta‐glucan receptor and Toll‐like receptor 2 , 2007, Cellular microbiology.

[56]  S. Yamaoka,et al.  Role of the Toll-like Receptor 4/NF-&kgr;B Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[57]  YoshihiroOgawa,et al.  Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages , 2007 .

[58]  C. Knauf,et al.  Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes , 2007 .

[59]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[60]  Makiko Kobayashi,et al.  Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering1 , 2006, The Journal of Immunology.

[61]  T. Muta,et al.  The Amino-terminal Region of Toll-like Receptor 4 Is Essential for Binding to MD-2 and Receptor Translocation to the Cell Surface* , 2004, Journal of Biological Chemistry.

[62]  K. Fukase,et al.  Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. , 2004, The Biochemical journal.

[63]  Makiko Kobayashi,et al.  Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. , 2004, International immunology.

[64]  B. Lindner,et al.  Aggregates Are the Biologically Active Units of Endotoxin* , 2004, Journal of Biological Chemistry.

[65]  S. Sonnino,et al.  A procedure for the preparation of GM3 ganglioside from GM1-lactone , 1999, Glycoconjugate Journal.

[66]  B. Monks,et al.  Lysines 128 and 132 Enable Lipopolysaccharide Binding to MD-2, Leading to Toll-like Receptor-4 Aggregation and Signal Transduction* , 2003, Journal of Biological Chemistry.

[67]  K. Fukase,et al.  Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2 , 2003, The Journal of experimental medicine.

[68]  R. Proia,et al.  Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  F. Gusovsky,et al.  Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist , 2003, Journal of Pharmacology and Experimental Therapeutics.

[70]  Kazuro Furukawa,et al.  Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides in Campylobacter jejuni Strains Associated with Guillain-Barré Syndrome , 2002, Infection and Immunity.

[71]  Y. Igarashi,et al.  Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[72]  K. Fukase,et al.  Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. , 2001, International immunology.

[73]  B. Reinhold,et al.  The major gangliosides of human peripheral blood monocytes/macrophages: absence of ganglio series structures. , 2001, Glycobiology.

[74]  T. Muta,et al.  Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. , 2001, European journal of biochemistry.

[75]  K. Fukase,et al.  A Divergent Synthesis of Lipid A and Its Chemically Stable Unnatural Analogues , 1999 .

[76]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[77]  M. Kiso,et al.  A facile, regio- and stereo-selective synthesis of ganglioside GM3. , 1989, Carbohydrate research.

[78]  H. Wieland,et al.  Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. , 1989, European journal of biochemistry.

[79]  S. Kusumoto,et al.  Total Synthesis of Escherichia coli Lipid A, the Endotoxically Active Principle of Cell-Surface Lipopolysaccharide , 1987 .

[80]  S. Kusumoto,et al.  Total synthesis of escherichia coli lipid A , 1985 .